Skip to main content
. 2015 Jul 29;56(5):1274–1287. doi: 10.3349/ymj.2015.56.5.1274

Table 3. Determination of the Genetic Effects of IL-10 and IL-6 Polymorphisms on TB and Subgroup Analysis.

Allele model Homozygous model Heterozygous model Dominant model Recessive model
Effect model OR (95% Cl) p value Effect model OR (95% Cl) p value Effect model OR (95% Cl) p value Effect model OR (95% Cl) p value Effect model OR (95% Cl) p value
IL-10-1082G/A G allele vs. A allele GG vs. AA AG vs. AA GG+AG vs. AA GG vs. AG+AA
 Ethnicity
  Overall 1.05(0.93,1.19) 0.423 1.15(0.87,1.51) 0.320 1.08(0.90,1.29) 0.393 1.09(0.91,1.31) 0.335 1.09(0.87,1.38) 0.448
  European 1.34(1.00,1.80) 0.054 1.88(0.93,3.80) 0.079 1.35(0.70,2.63) 0.369 1.49(0.79,2.79) 0.215 F1.69(1.19, 2.39) 0.003
  American F1.10(0.95,1.27) 0.201 F1.16(0.81,1.67) 0.421 F1.07 (0.88,1.30) 0.509 F1.09 (0.90,1,31) 0.372 F1.23 (0.90,1.68) 0.203
  Asian 0.85(0.67,1.09) 0.209 0.69(0.36,1.36) 0.285 0.91(0.66,1.26) 0.940 0.89(0.63,1.25) 0.494 0.67(0.36,1.26) 0.212
  African 1.12(0.91,1.38) 0.289 1.20(0.81,1.77) 0.369 1.32(0.93,1.87) 0.126 1.31 (0.92,1.88) 0.131 F0.97 (0.81,1.17) 0.761
 Sample types
  PTB 0.98(0.85,1.12) 0.726 0.93(0.70,1.25) 0.646 0.97(0.81,1.15) 0.691 0.96(0.80,1.15) 0.651 1.01 (0.76,1.34) 0.958
  PTB+EPTB 1.23(0.94,1.62) 0.130 2.00(1.16,3.45) 0.013 1.53(0.95,2.49) 0.084 1.56(0.97,2.52) 0.067 1.31 (0.89,1.93) 0.176
IL-10-819C/T T allele vs. C allele TT vs. CC TC vs. CC TT+TC vs. CC TT vs. TC+CC
 Ethnicity
  Overall F1.01 (0.95,1.07) 0.788 F1.01 (0.89,1.15) 0.834 1.21(1.00,1.46) 0.056 1.14(0.98,1.34) 0.099 F0.93 (0.84,1.03) 0.164
  European F0.92(0.71,1.19) 0.512 F0.75 (0.40,1.42) 0.380 F0.97 (0.68,1.37) 0.846 0.93(0.67,1.30) 0.678 F0.79 (0.43,1.44) 0.438
  American F1.04 (0.85,1.27) 0.732 F1.08(0.71,1.65) 0.721 F1.03 (0.76,1.39) 0.870 F1.04 (0.78,1.38) 0.799 F1.06 (0.72,1.57) 0.756
  Asian F1.08 (0.95,1.23) 0.265 F1.24 (0.92,1.67) 0.157 F1.34 (1.02,1.77) 0.035 F1.31 (1.01,1.70) 0.043 F1.01 (0.84,1.22) 0.897
  African F0.99 (0.92,1.07) 0.812 F0.97 (0.83, 1.13) 0.691 1.34(0.90,2.00) 0.148 1.21 (0.89,1.64) 0.231 F0.88 (0.77,1.01) 0.065
 Control source
  HB F1.01 (0.93,1.10) 0.785 F1.04 (0.87,1.24) 0.685 1.20(0.92,1.55) 0.175 1.13(0.92,1.39) 0.237 F0.93 (0.81,1.07) 0.310
  PB F1.01(0.92,1.09) 0.919 F0.99 (0.82,1.19) 0.908 1.26(0.89,1.78) 0.201 1.20(0.88,1.64) 0.258 F0.92 (0.79, 0.84) 0.339
IL-10-592A/C A allele vs. C allele AA vs. CC AC vs. CC AA+AC vs. CC AA vs. AC+CC
 Ethnicity
  Overall 1.07(0.95,1.19) 0.270 1.09(0.89,1.33) 0.401 F1.01 (0.91, 1.12) 0.839 1.06(0.91,1.22) 0.474 1.09(0.93,1.29) 0.291
  European F0.84 (0.65,1.09) 0.181 F0.64 (0.35,1.18) 0.153 F0.90(0.63,1.27) 0.536 F0.85 (0.61,1.18) 0.323 F0.68 (0.38,1.23) 0.204
  American 1.01(0.80,1.28) 0.918 F0.93 (0.72,1.20) 0.595 0.91(0.64,1.31) 0.623 0.97(0.67,1.39) 0.859 F1.07 (0.86,1.34) 0.545
  Asian F1.26 (1.08,1.45) 0.002 F1.50 (1.07, 2.12) 0.020 F1.21 (0.88,1.67) 0.250 F1.35 (0.99,1.83) 0.058 F1.33 (1.10,1.62) 0.004
  African 1.12(0.91,1.37) 0.290 1.12(0.79,1.58) 0.528 F1.11(0.97,1.27) 0.144 F1.09 (0.96,1.24) 0.175 1.08(0.77,1.52) 0.654
 Control source
  HB 1.08(0.94,1.24) 0.254 1.14(0.90,1.45) 0.289 F0.95(0.84,1.08) 0.429 1.07(0.89,1.29) 0.464 1.15(0.97,1.37) 0.111
  PB 1.00(0.89,1.1 1) 0.933 0.94(0.75,1.19) 0.607 F1.13(0.95,1.34) 0.154 1.08(0.91,1.22) 0.359 0.87(0.71,1.07) 0.194
IL-6-174G/C C allele vs. G allele CC vs. GG CG vs. GG CC+CG vs. GG CC vs. CG+GG
 Overall F0.77 (0.64, 0.91) 0.003 F0.67 (0.43,1.05) 0.078 F0.72(0.57, 0.90) 0.005 F0.71 (0.57, 0.88) 0.002 F0.77 (0.50,1.19) 0.243
 European F0.92 (0.67,1.26) 0.594 0.73(0.22,2.43) 0.610 F1.00(0.64,1.57) 0.987 F0.94 (0.62,1.42) 0.773 0.72(0.20,2.59) 0.615
 Asian F0.71 (0.54,0.93) 0.013 F0.69 (0.32,1.48) 0.343 F0.61 (0.44,0.85) 0.004 F0.63 (0.46, 0.86) 0.004 F0.93 (0.44,1.97) 0.855

TB, tuberculosis; PTB, pulmonary tuberculosis; EPTB, extra-pulmonary tuberculosis; PB, population-based controls; HB, hospital-based controls; R, random effect model; F, fixed effect model; IL-10, interleukin 10; IL-6, interleukin 6; CI, confidence interval; OR, odds ratio.